🇺🇸 FDA
Pipeline program

Azilsartan Medoxomil

AZI-P4-002

Approved small_molecule completed

Quick answer

Azilsartan Medoxomil for Essential Hypertension is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Essential Hypertension
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials